Folks with endocrine problems might even see their situation worsen because of COVID-19, based on a brand new evaluate revealed within the Journal of the Endocrine Society.
“We explored the previous SARS outbreak caused by the very similar virus SARS-CoV-1 to advise endocrinologists involved in the care of patients with COVID-19,” stated Noel Pratheepan Somasundaram of the Nationwide Hospital of Sri Lanka in Colombo, Sri Lanka. “The virus that causes COVID-19 — SARS-CoV-2 — binds to the ACE2 receptor, a protein which is expressed in lots of tissues. This permits the virus to enter endocrine cells and trigger the mayhem related to the illness.”
SARS-CoV-2 could cause lack of odor and achieve entry to the mind. In previous coronavirus infections such because the SARS epidemic in 2003, many sufferers developed a post-viral syndrome with fatigue. This might partly be brought on by adrenal insufficiency, a situation the place the adrenal glands don’t make sufficient cortisol, because of injury to the pituitary system. In the course of the SARS epidemic, sufferers who developed adrenal insufficiency sometimes recovered inside one 12 months.
“Testing for cortisol deficiency and treating patients with steroids may become a vital treatment strategy,” Somasundaram stated. “Very recent studies have demonstrated lowered mortality in severely-ill patients with COVID-19 treated with the steroid dexamethasone.”
COVID-19 additionally may result in new instances of diabetes and worsening of present diabetes. The SARS-CoV-2 virus attaches to ACE2, the principle entry level into cells for coronavirus, and disrupts insulin manufacturing, inflicting excessive blood glucose ranges in some sufferers. The authors spotlight the necessity for strict glucose monitoring in sufferers with COVID-19 as a measure to maximise restoration.
“People with vitamin D deficiency may be more susceptible to coronavirus and supplementation could improve outcomes, though evidence on the subject is mixed,” Somasundaram stated.
Reference: “The Impact of SARS-Cov-2 Virus Infection on the Endocrine System” 2 July 2020, Journal of the Endocrine Society.
Different authors embody: Ishara Ranathunga, Vithiya Ratnasamy, Piyumi Sachindra Alwis Wijewickrama, Harsha Anuruddhika Dissanayake, Nilukshana Yogendranathan, Manilka Sumanatilleke and Kavinga Kalhari Kobawaka Gamage of the Nationwide Hospital of Sri Lanka; Nipun Lakshitha de Silva of the Nationwide Hospital of Sri Lanka and the Basic Sir John Kotelawala Defence College in Colombo, Sri Lanka; Prasad Katulanda of the Nationwide Hospital of Sri Lanka and the College of Colombo in Sri Lanka; and Ashley Barry Grossman of the College of Oxford and Queen Mary College of London in the UK.
The research acquired no exterior funding.